Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Y6DO
|
|||
| Former ID |
DIB003534
|
|||
| Drug Name |
Streptokinase rectal suppository
|
|||
| Synonyms |
Proctokinase; Streptokinase rectal suppository (hemorrhoids); Streptokinase rectal suppository (hemorrhoids), CIGB
Click to Show/Hide
|
|||
| Indication | Hemorrhoids [ICD-11: DB60; ICD-10: K64.8] | Phase 3 | [1] | |
| Company |
Center for Genetic Engineering and Biotechnology
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Streptococcus Streptokinase (Stre-coc skc) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Recombinant streptokinase vs phenylephrine-based suppositories in acute hemorrhoids, randomized, controlled trial (THERESA-3). World J Gastroenterol. 2014 Feb 14;20(6):1594-601. | |||
| REF 2 | Pharmacovigilance program to monitor adverse reactions of recombinant streptokinase in acute myocardial infarction. BMC Clin Pharmacol. 2005 Nov 2;5:5. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.